Technology Archives - India press release

Home
Kolkata (West Bengal) [India], December 2: Curetek AI, a leader in advanced medical imaging and diagnostic intelligence, today announced a strategic partnership with AccuHealth Diagnostics to deploy its proprietary AI Pathology Laboratory Technology across AccuHealth’s expanding diagnostic network. This collaboration brings cutting-edge, AI-driven histopathology, cytology, and digital microscopy capabilities into AccuHealth’s laboratory ecosystem, marking a major advancement in the delivery of high-precision, technology-enabled diagnostics in Eastern India.

The partnership introduces next-generation AI-powered histopathology, cytology, and digital microscopy analysis into AccuHealth’s operations. This integration enhances diagnostic accuracy, reduces turnaround times, and enables high-volume, standardized reporting across AccuHealth’s centers and partner facilities. Curetek’s AI Pathology Suite supports automated slide interpretation, cell morphology analysis, anomaly detection, early cancer screening, and continuous quality assurance–empowering pathologists with faster, more consistent, and data-driven insights. “AccuHealth’s scale and commitment to quality make them the ideal partner for deploying Curetek’s AI Pathology innovations,” said Somenath Chatterjee, Founder & CEO, Curetek AI. “Together, we are raising the bar for digital pathology and improving patient care at scale.” “Integrating Curetek’s AI Pathology platform makes AccuHealth one of India’s pioneers in AI-enabled laboratory medicine,” said Anirban Das, Chairman, AccuHealth Diagnostics. “Our focus is on delivering faster, more accurate, and more affordable diagnostics to every patient.” Curetek AI continues to expand its footprint across multiple clinical specialties, including radiology pattern recognition, cardiology signal interpretation, pediatric health analytics, and oncology screening models. The company is strengthening its research collaborations with medical institutions, enhancing training datasets, and building interoperable AI modules designed for seamless integration into laboratory information systems (LIS) and hospital platforms. This partnership marks a major milestone in AccuHealth’s digital transformation journey. By embedding AI directly into laboratory workflows, AccuHealth aims to enhance operational efficiency, deliver consistent diagnostic excellence across its network, and expand its capabilities in preventive health and advanced disease screening. Together, the two organizations are poised to shape the future of technology-enabled laboratory medicine in India.
Fashion
Kolkata (West Bengal) [India], December 2: Curetek AI, a leader in advanced medical imaging and diagnostic intelligence, today announced a strategic partnership with AccuHealth Diagnostics to deploy its proprietary AI Pathology Laboratory Technology across AccuHealth’s expanding diagnostic network. This collaboration brings cutting-edge, AI-driven histopathology, cytology, and digital microscopy capabilities into AccuHealth’s laboratory ecosystem, marking a major advancement in the delivery of high-precision, technology-enabled diagnostics in Eastern India.

The partnership introduces next-generation AI-powered histopathology, cytology, and digital microscopy analysis into AccuHealth’s operations. This integration enhances diagnostic accuracy, reduces turnaround times, and enables high-volume, standardized reporting across AccuHealth’s centers and partner facilities. Curetek’s AI Pathology Suite supports automated slide interpretation, cell morphology analysis, anomaly detection, early cancer screening, and continuous quality assurance–empowering pathologists with faster, more consistent, and data-driven insights. “AccuHealth’s scale and commitment to quality make them the ideal partner for deploying Curetek’s AI Pathology innovations,” said Somenath Chatterjee, Founder & CEO, Curetek AI. “Together, we are raising the bar for digital pathology and improving patient care at scale.” “Integrating Curetek’s AI Pathology platform makes AccuHealth one of India’s pioneers in AI-enabled laboratory medicine,” said Anirban Das, Chairman, AccuHealth Diagnostics. “Our focus is on delivering faster, more accurate, and more affordable diagnostics to every patient.” Curetek AI continues to expand its footprint across multiple clinical specialties, including radiology pattern recognition, cardiology signal interpretation, pediatric health analytics, and oncology screening models. The company is strengthening its research collaborations with medical institutions, enhancing training datasets, and building interoperable AI modules designed for seamless integration into laboratory information systems (LIS) and hospital platforms. This partnership marks a major milestone in AccuHealth’s digital transformation journey. By embedding AI directly into laboratory workflows, AccuHealth aims to enhance operational efficiency, deliver consistent diagnostic excellence across its network, and expand its capabilities in preventive health and advanced disease screening. Together, the two organizations are poised to shape the future of technology-enabled laboratory medicine in India.
General News
Kolkata (West Bengal) [India], December 2: Curetek AI, a leader in advanced medical imaging and diagnostic intelligence, today announced a strategic partnership with AccuHealth Diagnostics to deploy its proprietary AI Pathology Laboratory Technology across AccuHealth’s expanding diagnostic network. This collaboration brings cutting-edge, AI-driven histopathology, cytology, and digital microscopy capabilities into AccuHealth’s laboratory ecosystem, marking a major advancement in the delivery of high-precision, technology-enabled diagnostics in Eastern India.

The partnership introduces next-generation AI-powered histopathology, cytology, and digital microscopy analysis into AccuHealth’s operations. This integration enhances diagnostic accuracy, reduces turnaround times, and enables high-volume, standardized reporting across AccuHealth’s centers and partner facilities. Curetek’s AI Pathology Suite supports automated slide interpretation, cell morphology analysis, anomaly detection, early cancer screening, and continuous quality assurance–empowering pathologists with faster, more consistent, and data-driven insights. “AccuHealth’s scale and commitment to quality make them the ideal partner for deploying Curetek’s AI Pathology innovations,” said Somenath Chatterjee, Founder & CEO, Curetek AI. “Together, we are raising the bar for digital pathology and improving patient care at scale.” “Integrating Curetek’s AI Pathology platform makes AccuHealth one of India’s pioneers in AI-enabled laboratory medicine,” said Anirban Das, Chairman, AccuHealth Diagnostics. “Our focus is on delivering faster, more accurate, and more affordable diagnostics to every patient.” Curetek AI continues to expand its footprint across multiple clinical specialties, including radiology pattern recognition, cardiology signal interpretation, pediatric health analytics, and oncology screening models. The company is strengthening its research collaborations with medical institutions, enhancing training datasets, and building interoperable AI modules designed for seamless integration into laboratory information systems (LIS) and hospital platforms. This partnership marks a major milestone in AccuHealth’s digital transformation journey. By embedding AI directly into laboratory workflows, AccuHealth aims to enhance operational efficiency, deliver consistent diagnostic excellence across its network, and expand its capabilities in preventive health and advanced disease screening. Together, the two organizations are poised to shape the future of technology-enabled laboratory medicine in India.
Health
Kolkata (West Bengal) [India], December 2: Curetek AI, a leader in advanced medical imaging and diagnostic intelligence, today announced a strategic partnership with AccuHealth Diagnostics to deploy its proprietary AI Pathology Laboratory Technology across AccuHealth’s expanding diagnostic network. This collaboration brings cutting-edge, AI-driven histopathology, cytology, and digital microscopy capabilities into AccuHealth’s laboratory ecosystem, marking a major advancement in the delivery of high-precision, technology-enabled diagnostics in Eastern India.

The partnership introduces next-generation AI-powered histopathology, cytology, and digital microscopy analysis into AccuHealth’s operations. This integration enhances diagnostic accuracy, reduces turnaround times, and enables high-volume, standardized reporting across AccuHealth’s centers and partner facilities. Curetek’s AI Pathology Suite supports automated slide interpretation, cell morphology analysis, anomaly detection, early cancer screening, and continuous quality assurance–empowering pathologists with faster, more consistent, and data-driven insights. “AccuHealth’s scale and commitment to quality make them the ideal partner for deploying Curetek’s AI Pathology innovations,” said Somenath Chatterjee, Founder & CEO, Curetek AI. “Together, we are raising the bar for digital pathology and improving patient care at scale.” “Integrating Curetek’s AI Pathology platform makes AccuHealth one of India’s pioneers in AI-enabled laboratory medicine,” said Anirban Das, Chairman, AccuHealth Diagnostics. “Our focus is on delivering faster, more accurate, and more affordable diagnostics to every patient.” Curetek AI continues to expand its footprint across multiple clinical specialties, including radiology pattern recognition, cardiology signal interpretation, pediatric health analytics, and oncology screening models. The company is strengthening its research collaborations with medical institutions, enhancing training datasets, and building interoperable AI modules designed for seamless integration into laboratory information systems (LIS) and hospital platforms. This partnership marks a major milestone in AccuHealth’s digital transformation journey. By embedding AI directly into laboratory workflows, AccuHealth aims to enhance operational efficiency, deliver consistent diagnostic excellence across its network, and expand its capabilities in preventive health and advanced disease screening. Together, the two organizations are poised to shape the future of technology-enabled laboratory medicine in India.
Lifestyle
Kolkata (West Bengal) [India], December 2: Curetek AI, a leader in advanced medical imaging and diagnostic intelligence, today announced a strategic partnership with AccuHealth Diagnostics to deploy its proprietary AI Pathology Laboratory Technology across AccuHealth’s expanding diagnostic network. This collaboration brings cutting-edge, AI-driven histopathology, cytology, and digital microscopy capabilities into AccuHealth’s laboratory ecosystem, marking a major advancement in the delivery of high-precision, technology-enabled diagnostics in Eastern India.

The partnership introduces next-generation AI-powered histopathology, cytology, and digital microscopy analysis into AccuHealth’s operations. This integration enhances diagnostic accuracy, reduces turnaround times, and enables high-volume, standardized reporting across AccuHealth’s centers and partner facilities. Curetek’s AI Pathology Suite supports automated slide interpretation, cell morphology analysis, anomaly detection, early cancer screening, and continuous quality assurance–empowering pathologists with faster, more consistent, and data-driven insights. “AccuHealth’s scale and commitment to quality make them the ideal partner for deploying Curetek’s AI Pathology innovations,” said Somenath Chatterjee, Founder & CEO, Curetek AI. “Together, we are raising the bar for digital pathology and improving patient care at scale.” “Integrating Curetek’s AI Pathology platform makes AccuHealth one of India’s pioneers in AI-enabled laboratory medicine,” said Anirban Das, Chairman, AccuHealth Diagnostics. “Our focus is on delivering faster, more accurate, and more affordable diagnostics to every patient.” Curetek AI continues to expand its footprint across multiple clinical specialties, including radiology pattern recognition, cardiology signal interpretation, pediatric health analytics, and oncology screening models. The company is strengthening its research collaborations with medical institutions, enhancing training datasets, and building interoperable AI modules designed for seamless integration into laboratory information systems (LIS) and hospital platforms. This partnership marks a major milestone in AccuHealth’s digital transformation journey. By embedding AI directly into laboratory workflows, AccuHealth aims to enhance operational efficiency, deliver consistent diagnostic excellence across its network, and expand its capabilities in preventive health and advanced disease screening. Together, the two organizations are poised to shape the future of technology-enabled laboratory medicine in India.
Arts & Entertainment
Kolkata (West Bengal) [India], December 2: Curetek AI, a leader in advanced medical imaging and diagnostic intelligence, today announced a strategic partnership with AccuHealth Diagnostics to deploy its proprietary AI Pathology Laboratory Technology across AccuHealth’s expanding diagnostic network. This collaboration brings cutting-edge, AI-driven histopathology, cytology, and digital microscopy capabilities into AccuHealth’s laboratory ecosystem, marking a major advancement in the delivery of high-precision, technology-enabled diagnostics in Eastern India.

The partnership introduces next-generation AI-powered histopathology, cytology, and digital microscopy analysis into AccuHealth’s operations. This integration enhances diagnostic accuracy, reduces turnaround times, and enables high-volume, standardized reporting across AccuHealth’s centers and partner facilities. Curetek’s AI Pathology Suite supports automated slide interpretation, cell morphology analysis, anomaly detection, early cancer screening, and continuous quality assurance–empowering pathologists with faster, more consistent, and data-driven insights. “AccuHealth’s scale and commitment to quality make them the ideal partner for deploying Curetek’s AI Pathology innovations,” said Somenath Chatterjee, Founder & CEO, Curetek AI. “Together, we are raising the bar for digital pathology and improving patient care at scale.” “Integrating Curetek’s AI Pathology platform makes AccuHealth one of India’s pioneers in AI-enabled laboratory medicine,” said Anirban Das, Chairman, AccuHealth Diagnostics. “Our focus is on delivering faster, more accurate, and more affordable diagnostics to every patient.” Curetek AI continues to expand its footprint across multiple clinical specialties, including radiology pattern recognition, cardiology signal interpretation, pediatric health analytics, and oncology screening models. The company is strengthening its research collaborations with medical institutions, enhancing training datasets, and building interoperable AI modules designed for seamless integration into laboratory information systems (LIS) and hospital platforms. This partnership marks a major milestone in AccuHealth’s digital transformation journey. By embedding AI directly into laboratory workflows, AccuHealth aims to enhance operational efficiency, deliver consistent diagnostic excellence across its network, and expand its capabilities in preventive health and advanced disease screening. Together, the two organizations are poised to shape the future of technology-enabled laboratory medicine in India.
Technology
Kolkata (West Bengal) [India], December 2: Curetek AI, a leader in advanced medical imaging and diagnostic intelligence, today announced a strategic partnership with AccuHealth Diagnostics to deploy its proprietary AI Pathology Laboratory Technology across AccuHealth’s expanding diagnostic network. This collaboration brings cutting-edge, AI-driven histopathology, cytology, and digital microscopy capabilities into AccuHealth’s laboratory ecosystem, marking a major advancement in the delivery of high-precision, technology-enabled diagnostics in Eastern India.

The partnership introduces next-generation AI-powered histopathology, cytology, and digital microscopy analysis into AccuHealth’s operations. This integration enhances diagnostic accuracy, reduces turnaround times, and enables high-volume, standardized reporting across AccuHealth’s centers and partner facilities. Curetek’s AI Pathology Suite supports automated slide interpretation, cell morphology analysis, anomaly detection, early cancer screening, and continuous quality assurance–empowering pathologists with faster, more consistent, and data-driven insights. “AccuHealth’s scale and commitment to quality make them the ideal partner for deploying Curetek’s AI Pathology innovations,” said Somenath Chatterjee, Founder & CEO, Curetek AI. “Together, we are raising the bar for digital pathology and improving patient care at scale.” “Integrating Curetek’s AI Pathology platform makes AccuHealth one of India’s pioneers in AI-enabled laboratory medicine,” said Anirban Das, Chairman, AccuHealth Diagnostics. “Our focus is on delivering faster, more accurate, and more affordable diagnostics to every patient.” Curetek AI continues to expand its footprint across multiple clinical specialties, including radiology pattern recognition, cardiology signal interpretation, pediatric health analytics, and oncology screening models. The company is strengthening its research collaborations with medical institutions, enhancing training datasets, and building interoperable AI modules designed for seamless integration into laboratory information systems (LIS) and hospital platforms. This partnership marks a major milestone in AccuHealth’s digital transformation journey. By embedding AI directly into laboratory workflows, AccuHealth aims to enhance operational efficiency, deliver consistent diagnostic excellence across its network, and expand its capabilities in preventive health and advanced disease screening. Together, the two organizations are poised to shape the future of technology-enabled laboratory medicine in India.

Latest post

Yuva Sangam 2025 Inspires Over 10,000 Youth through Sports, Arts and Cultural Harmony

Biofactor Biologicals Launches “BIOLMIN Kit” — India’s First Integrated Soil-to-Yield Biological Nutrition Programme

Silver Denims Launches in Mumbai With Paris Designed Jewellery, 1 Hour Delivery and Exclusive Limited Collections

Popular Posts

GNC India Launches Creatine + Electrolytes: A Revolutionary Hydration-Focused Performance Formula (1012)

Advance Your Career with Zell Education – Your Gateway to ACCA, CFA, CMA, and More (853)

Alt DRX Blockchain Technology Makes Real Estate Investable for Everyone (813)

Naadbramha Idli: A Journey from a Small Restaurant to 47+ Franchises (745)

Teaser video of popular YouTuber Nakayama Kinni-kun’s cover song ‘Muscles Please!’ with Singing Cosplayer Hikari, out now! (612)

Stay Connected

Category: Technology

Curetek AI Licenses Proprietary AI Pathology Technology to AccuHealth Diagnostics

Tecell Launches Industry-Revolutionizing EV Charging Hub to Transform India and Global Markets

Laser Beam Transmission Technology Developed in India to Compete with Industry Giants

Innovation for Every Life: Taiwan Excellence Winners Transforming Daily Experiences

AI Meets Rugged Reliability: Getac Expands Its Range of Versatile Rugged Field Devices with Launch of New AI-Ready V120 Laptop and F120 Tablet

Getac’s S510AD Blends Outstanding AI-Powered Performance with Sustainable Manufacturing in a Versatile Rugged Form Factor

VCreaTek Unveils a Bold New Brand Identity, Marking the Next Phase of Its Global Growth

ATOMESUS AI Set to Go Live Soon — Designed by India’s ISRO-Skilled Innovators

Kimbal Teams Up with MicroEJ to Power Next-Generation Smart Meters and Accelerate Its Global Expansion

ATOMESUS AI Set to Become the World’s Best AI in 2026 — The Most Affordable, Fast, and User-Friendly Intelligence Built by India’s Young Innovators

Popular Post

GNC India Launches Creatine + Electrolytes: A Revolutionary Hydration-Focused Performance Formula (1012)

Advance Your Career with Zell Education – Your Gateway to ACCA, CFA, CMA, and More (853)

Alt DRX Blockchain Technology Makes Real Estate Investable for Everyone (813)

Naadbramha Idli: A Journey from a Small Restaurant to 47+ Franchises (745)

Teaser video of popular YouTuber Nakayama Kinni-kun’s cover song ‘Muscles Please!’ with Singing Cosplayer Hikari, out now! (612)

Newsletter

Weather